Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Phase 2 Unknown 30 enrolled University of Magdeburg

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Phase II study for treatment of patients with relapsed or primary refractory aggressive B- cell NHL and anthracycline chemotherapy pretreatment, who received or did not qualify for autologous stem cell transplantation.

Timeline

Start: 2004-08
Primary completion: —
Completion: 2010-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bendamustine	Small molecule	—	—
Subject	Rituximab	Monoclonal antibody	—	—

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Summary

Timeline

Drugs

Indications